drugIndia
Cart
Already at best price
Glimican MV 303 Tablet SR

Glimican MV 303 Tablet SR

Glimepiride (3mg) + Voglibose (0.3mg) + Metformin (500mg)

Alican Pharmaceutical Pvt Ltd
Schizophrenia
108.00135.0020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
108.0020% OFF
135.00

About This Medicine

Product description & overview

Glimican MV 303 Tablet SR: A Versatile Diabetes Management Solution

Glimican MV 303 Tablet SR combines three powerful ingredients – Glimepiride, Metformin, and Voglibose - in a single convenient dosage form for effective management of type 2 diabetes. This unique combination aims to improve blood glucose control by targeting different aspects of the disease:

* Glimepiride (3mg): A sulfonylurea that stimulates insulin release from beta cells in the pancreas, increasing blood glucose levels.
* Metformin (500mg): An initial-line drug for type 2 diabetes that reduces hepatic glucose production and improves insulin sensitivity.
* Voglibose (0.3mg): A selective α-glucosidase inhibitor that slows down the absorption of glucose from the stomach, ultimately lowering postprandial blood sugar levels.

This combination offers comprehensive control over both short-term and long-term blood sugar management, making it ideal for individuals with type 2 diabetes seeking an efficient and convenient treatment solution.

Note: Always consult a healthcare professional before using any medication, including Glimican MV 303 Tablet SR. This description is provided for informational purposes only and does not substitute medical advice.

Active composition

Glimepiride 3 mg

+2 more active ingredients

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
3 mg

All Active Ingredients

Glimepiride3 mg
Voglibose0.3 mg
Metformin500 mg

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glimican MV 303 Tablet SR.

High Risk

Pregnancy

Glimican MV 303 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glimican MV 303 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glimican MV 303 Tablet SR may be needed. Please consult your doctor. Glimican MV 303 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glimican MV 303 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glimican MV 303 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glimican MV 303 Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Glimican MV 303 Tablet SR

Products matching your search